Twenty of Arizona’s highest-achieving high-school seniors have been named Flinn Scholars and will receive scholarships to Arizona’s three public research universities valued at more than $120,000. The merit-based award—which recipients accept in many instances over admission to the nation’s most…

The Flinn Foundation hosted its three annual Arizona’s Bioscience Roadmap Progress Report Update luncheons this week to dialogue about Arizona’s latest advancements in bioscience research and industry with leaders in Flagstaff, Tucson, and Phoenix. The Latest Progress of the Biosciences…

The Flinn Foundation and The Arizona Republic have entered into a grant-based partnership that will enable the state’s largest media platform to pursue a multimedia initiative to deepen public understanding of the biosciences in Arizona, including research, industry development, and…

The Flinn Foundation has surpassed $1 million in funding support to benefit Arizona bioscience startup companies with the selection of six firms to participate in the foundation’s 2019 Bioscience Entrepreneurship Program. The Flinn Foundation has selected 34 Arizona bioscience firms…

The HonorHealth vice president of research and a retired executive at W.L. Gore & Associates, Inc. have assumed new leadership roles with a statewide committee charged with advancing the biosciences in Arizona. Mark Slater has been named chair and Eve…

Thirty Arizonans have been selected for the 2019 Flinn-Brown Civic Leadership Academy by the Arizona Center for Civic Leadership at the Flinn Foundation. In addition to representatives from the Phoenix metro area, eight of the Flinn-Brown Fellows are from northern,…

Celgene, which has operated a biopharmaceutical manufacturing plant in Phoenix for nearly a decade, has been acquired by Bristol-Myers Squibb for about $74 billion, a merger that creates a global biopharma company with a focus on patients with cancer, inflammatory…